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Pancreatitis associated protein I is a secretory stress
protein ®rst characterized in pancreas during
pancreatitis but also expressed in several tissues
including hepatic, gastric, and colon cancer. Its con-
centration in serum can be signi®cant. The relation-
ship of pancreatitis associated protein I to skin
cancers was investigated in normal melanocytes,
melanoma tumors, and melanoma cell lines. None of
them expressed pancreatitis associated protein I,
even after stress induction. Adenovirus-mediated
pancreatitis associated protein I expression, however,
reduced cell adhesion to laminin-1 and ®bronectin
with a loss of integrin participation. Pancreatitis
associated protein I expression stimulated haptotactic
and directed migrations of some melanoma cells,
but only directed migration was activated in normal
melanocytes. Importantly, directed migration and
spreading on ®bronectin of the responsive melanoma
cells were also enhanced when puri®ed rat pancreat-
itis associated protein I was added to the culture
medium of noninfected cells. This indicates that
effects in infected cells were elicited by pancreatitis
associated protein I after its secretion. Exogenous
pancreatitis associated protein I can therefore modify
the adhesion and motility of normal and transformed
melanocytes, suggesting a potential interaction with
melanoma invasivity. Key words: adenoviral vector/base-
ment membrane/cell invasion/vitiligo. J Invest Dermatol
116:426±433, 2001
P
ancreatitis associated protein I (PAP-I) belongs to the
PAP/reg family of proteins that are overexpressed in the
exocrine pancreas during acute pancreatitis (Iovanna
et al, 1991). The molecular characterization of PAP-I
revealed that it was a calcium-dependent lectin.
Structure and chromosomal assignment of its gene have been
described (Lasserre et al, 1992, 1994; Orelle et al, 1992; Bartoli et al,
1998). PAP-I expression was eventually demonstrated in several
tissues (Lasserre et al, 1992; Bartoli et al, 1998; Motoo et al, 1998)
and its serum concentration can be elevated (Iovanna et al, 1994;
van der Pijl et al, 1996). Its biologic functions remain elusive,
however. Some data support its involvement in tissue regeneration
and cell proliferation (Watanabe et al, 1994; Zenilman et al, 1996;
Livesey et al, 1997; Ortiz et al, 1998). The interesting observation
that PAP-I was upregulated in human colorectal (Motoo et al,
1998; Rechreche et al, 1999), gastric (Motoo et al, 1998, 1999), and
hepatocellular (Lasserre et al, 1992; Christa et al, 1996) carcinomas
suggested a role in cancer. Nevertheless, the relevance of PAP-I in
malignant skin tumors has not been investigated.
Melanoma is one of the fastest growing cancers in incidence
throughout the world (Berwick and Halpern, 1997; Brown and
Nelson, 1999). This very invasive neoplasm originates from the
malignant transformation of melanocytes, the pigmented cuta-
neous cells responsible for skin color. Its prognosis is poor and
a better understanding of the mechanisms underlying its
development is required to develop new therapeutic strategies
(Weterman et al, 1994; Meier et al, 1998). In this work, we
took advantage of the availability of cultured melanocytes and
melanoma cell lines to study the in¯uence of PAP-I on
parameters of melanoma progression, particularly cell adhesion
and motility.
MATERIALS AND METHODS
Cell cultures Normal human melanocytes were obtained from foreskins of
infants after elective circumcision, according to a modi®cation of the method
described by Eisinger and Marko (1982). Foreskins were cut in small 4 mm2
fragments and treated overnight at 4°C with 1.25 U per ml Dispase grade II
(Roche Molecular Biochemicals, Meylan, France) in phosphate-buffered
saline solution (PBS). This allowed dermal-epidermal separation by peeling
off the epidermis, which was then treated with a trypsin-ethylenediamine
tetraacetic acid solution (0.05%±0.02% in PBS) for 2 min at 37°C. A cell
suspension was obtained by gentle mechanical dissociation of the epidermis
and was plated at 90 3 103 cells per cm2 in culture dishes containing the
following semide®ned selective ``melanocyte culture medium'': MCDB 153
medium (Sigma, St. Louis, MO) supplemented with 30 mg per ml bovine
pituitary extract (Life Technologies, Paisley, U.K.), 2% fetal bovine serum
(FBS) (Dominique Dutscher, Brumath, France), 16 nM phorbol-12-
myristate-13-acetate (Sigma), 5 mg per ml insulin, and 1.1 mM hydro-
cortisone (Sigma). Cells were grown in a humidifed atmosphere containing
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6% CO2 in air at 37°C. Melanocytes could grow for up to eight passages, and
were generally used at passages 3±5 for experiments.
Normal human keratinocytes were also obtained from infant foreskins
and cultured as already described (Benoliel et al, 1997).
SK-MEL-2 (ATCC cat. HTB-68, Manassas, VA) and SK-MEL-5
(ATCC cat. HTB-70) melanoma cell lines were cultured in MEM medium
(Sigma) whereas KAL melanoma cell line (Cohen-Knafo et al, 1995) was
cultured in RPMI medium. HBL melanoma cell line (Del Marmol et al,
1996) was grown in MCDB153 medium. All media contained 10% FBS.
Ultraviolet B (UVB) irradiations of the cells at ¯uence of 100 mJ per cm2
were performed with a Bio-Sun apparatus (Vilbert Lourmat, Marne-la-
ValleÂe, France). It delivers a calibrated computer-assisted beam of 312 nm
wavelength (4 measures per s) at a resolution of 0.01 mW per cm2. During
irradiations, cells were covered with a PBS ®lm containing magnesium and
calcium.
Melanoma tumors Twelve cutaneous melanoma tumors, snap-frozen
in liquid nitrogen, were obtained from patients at the Department of
Dermatology, St. Marguerite Hospital, Marseille. Informed consent from
living patients was obtained after agreement of the committee on ethics.
The tumors were classi®ed from clinical stages I to IV according to the
American Joint Committee on Cancer/Union Internationale Contre le
Cancer (AJCC, UICC 1992).
Adenovirus vector and infection experiments As already described
(Bodeker et al, 1998), the 780 base pair cDNA of human PAP-I (Dusetti
et al, 1996) was inserted into the XbaI-BamH1 restriction site of the
pDE1sp1B shuttle vector (McGrory et al, 1988) to give the pDE1sp1B-PAP
construct. The cytomegalovirus (CMV) promoter was inserted into the
SalI-HindIII restriction site of the pDE1sp1B-PAP, giving the pDE1sp1B-
CMV-PAP construct (Ad-PAP). Control adenovirus Ad-CAT resulted
from insertion of the bacterial chloramphenicol acetyl transferase cDNA in
place of the PAP-I cDNA. To optimize experimental conditions for
adenoviral infection in melanocytic cells, a pDE1sp1B-CMV-GFP
construct was made. GFP, the green ¯uorescent protein (De Martin et al,
1997), allowed evaluation of infection yield and kinetics of protein
expression. Both GFP and PAP-I infection at 40 multiplicity of infection
per cell for 15 h allowed a 64%±98% labeling of melanocytic cells, as
determined by cyto¯uorimetry after 24 h. PAP was detected by
immuno¯uorescent staining with the polyclonal antibody H8 (Iovanna
et al, 1993). No loss of cell viability occurred, as judged by cleavage assay of
the tetrazolium salt WST-1 (Roche Molecular Biochemicals).
Immunoaf®nity puri®cation of rat PAP-I PAP-I was puri®ed from
the pancreatic juice obtained from a rat with acute pancreatitis. A speci®c
antibody against rat PAP-I (Iovanna et al, 1993) was covalently bound to a
solid matrix (Af®-Gel 10, BioRad, Hercules, CA) according to the
manufacturer's speci®cations. The column was equilibrated with 2-[N-
morpholino] ethane sulfonic acid (MES) buffer (20 mM, pH 6.5) with
150 mM NaCl. Lyophilized pancreatic juice was resuspended in MES
buffer (20 mM, pH 6.5), 150 mM NaCl, 5 mM benzamidine, 2 mM
phenylmethylsulfonyl ¯uoride, and 5 mM sodium benzoyl-L.arginin.
After centrifugation (3000g for 15 min), the supernatant was applied to
the af®nity column and recirculated overnight at 4°C. The column was
washed with MES buffer to elute unbound contaminants. The bound
protein was eluted with glycine buffer (200 mM, pH 2.8), dialyzed against
PBS, and concentrated with a Vivaspeed 15 ml concentrator (Vitascience).
RNA extraction and reverse transcriptase±polymerase chain
reaction (RT-PCR) analysis Total RNA from cells or tumors was
obtained by using the TRIZOL reagent according to the protocol supplied
by the manufacturer (Life Technologies). 0.5 mg of total RNA was reverse-
transcribed and ampli®ed in one step by the TITAN RT-PCR kit from
Roche Molecular Biologicals, using the following speci®c primers for
human PAP cDNA: 5¢-GGTGAAGAACCCCAGAGGGA-3¢ and 5¢-
CTAGTCAGTGAACTTGCAGA-3¢. b-actin primers (5¢-TGGTGG-
GTATGGGTCAGAAGG-3¢ and 5¢-ATCCTGTCAGCGATGCCT-
GGG-3¢) were used as PCR control on the same RNA preparation.
Conditions for ampli®cation were ®ve cycles of 94°C for 2 min, 71°C for
2 min, 72°C for 2 min, followed by 30 cycles of 94°C for 10 s, 55°C for
2 min, and 72°C for 2 min. Ampli®cation was terminated by heating at
72°C for 10 min. The PCR products were analyzed by electrophoresis on a
2% agarose gel according to standard procedures and visualized by UV
transillumination.
Analysis of integrin expression by ¯ow cytometry Melanocytes
were trypsinized and recovered at 4°C in MCDB153 culture medium
containing 10% FBS. After centrifugation, the cell pellet was resuspended
in MCDB153 containing 1% heat-denatured bovine serum albumin (HD-
BSA). Melanocytes were incubated with 5 mg per ml of the respective anti-
integrin antibodies for 1 h at 4°C. Control cells were incubated with 5 mg
per ml Ig from nonimmune mouse serum (MOPC 21). After washing with
PBS, melanocytes were incubated for 45 min at 4°C with ¯uorescein-
isothiocyanate-conjugated antimouse IgG before ¯uorescence analysis with
an EPICS scan ¯ow cytometer (Coulter, Coultronics France, Margency,
France). Fluorescence was measured in arbitrary units on a logarithmic
scale. Antibodies against integrin subunits were the following: anti-a3
P1B5 (Chemicon, Temecula, CA), anti-a2 Gi9, anti-a5 SAM1, anti-a6
GoH3 (all from Immunotech-Coulter, Marseille, France). The anti-aV
antibody was a gift of Pr. Marvaldi (UniversiteÂ de la MeÂditerraneÂe, FaculteÂ
de Pharmacie, Marseille, France). Control ascite ¯uid from nonimmune
mouse (MOPC 21) was from Sigma.
Cell substrate adhesion assay Experimental procedures for adhesion
assay have been described already (Verrando et al, 1994). Brie¯y, 96-well
plates were coated overnight at 4°C with either 20 mg per ml HD-BSA
(control), laminin I (Sigma), 30 mg per ml ®bronectin, or 30 mg per ml
collagen I (or, when mentioned, collagen IV). After PBS washes, the wells
were blocked by 1% HD-BSA. Trypsinized cells were deposited into the
wells and allowed to adhere for 1 h at 37°C, before washing off the
remaining nonadherent cells. When the above-mentioned function-
blocking antibodies to integrin subunits were used (20 mg per ml ®nal
concentration), they were added during that incubation. In this study,
adhesion rates were evaluated by staining the adherent cells for 15 min with
a solution of 0.1% crystal violet (Sigma) after their ®xation by 1%
glutaraldehyde in PBS for 20 min. After PBS washes, 50 ml of 1% sodium
dodecyl sulfate solution was added to the wells, and optical density
(adhesion rate) was determined by spectrophotometry at 550 nm. Each
measure was the average of ®ve determinations.
Migration assays An adaptation of the phagokinetic track assay of
Albrecht-Buehler (Albrecht-Buehler, 1977) reported in a previous work
was used (Benoliel et al, 1997). Colloidal gold particles were deposited on
BSA-treated coverslips and coated with 10 mg per ml extracellular matrix
components (see Results) or HD-BSA (control) prior to deposition of the
melanocytic cells. Cells were allowed to migrate (haptotactic migration) for
4 h at 37°C in their respective culture medium containing 1% BSA in the
absence of growth factors (BPE, serum, insulin). Cells were then ®xed with
1% formaldehyde. Computer-assisted image analysis of the particle-free
tracks left by the migratory cells allowed a measure of their surface, and the
ratio between that surface and the surface of the total microscopic ®eld gave
the migration index. Wells were duplicated and at least ®ve ®elds per well
were analyzed.
Transmigration and invasion assays The upper side of a modi®ed
Boyden chamber polycarbonate membrane (Transwell 24, 8 mm pore,
Costar, Cambridge, MA) was either left uncoated (transmigration) or
coated (invasion) with Matrigel (1 mg per ml) (Matrigel-GFR, Falcon-
Becton Dickinson, Bedford, MA) for 2 h at room temperature. Lower
chambers coated with 1% HD-BSA were ®lled with respective melanocytic
cell culture medium without FBS and containing 25 mg per ml ®bronectin
as chemoattractant. In other experiments with nontransfected cells, rat PAP
puri®ed by immunoaf®nity from pancreatic juice was added at 1 or 10 ng
per ml (60 or 600 pM). Melanocytic cells were then seeded in the upper
chambers in their respective culture medium without FBS and incubated
for either 12±24 h (transmigration) or 48 h (invasion) at 37°C. After a
10 min ®xation step in 10% formaldehyde, the cells were permeabilized
with 0.5% Triton X-100 for 5 min. Melanocytic cells from the upper
chamber were removed and nuclei on the bottom were stained with
propidium iodide and counted under an inverted-epi¯uorescent
microscope (IX70, Olympus, Rungis, France). Wells were duplicated
and ®ve ®elds per well were analyzed.
Cell spreading The bottom of chamber slides (Labtek, Nunc, Roskilde,
Denmark) was coated overnight at 4°C with 30 mg per ml ®bronectin as for
cell substrate adhesion assays. Ten nanograms per milliliter of puri®ed
PAP-I were added to the respective FBS-free culture medium of
melanocytic cells, except for controls. The cells were recovered after 3 h
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by trypsinization and centrifugation after addition of trypsin inhibitor, and
were then seeded into the coated chamber slides. They were allowed to
attach and spread for 1 h at 37°C in a cell culture incubator, in their
respective FBS-free culture medium containing or not (control) 10 ng
per ml PAP-I. It was veri®ed that this period of time was optimum to see
good spreading differences between assay and control for each cell type.
After PBS washes, cells were ®xed with formaldehyde, permeabilized with
0.1% Triton X-100, and reacted 30 min with a rhodamine-phalloidin
solution to label the actin cytoskeleton. Cell spreading was observed with
an inverted epi¯uorescence microscope (IX70, Olympus).
Statistical analysis Statistical signi®cance was estimated with the
nonparametric test of Mann±Whitney.
RESULTS
PAP-I is not expressed in cultured melanocytic cells and in
melanoma tumors PAP-I expression in cultured normal human
melanocytes, in the two melanoma cell lines SK-MEL-2 and KAL,
as well as in 12 resected melanoma tumors spanning the clinical
stages I to IV was ®rst assessed by indirect immuno¯uorescence
with a polyclonal antibody to human PAP-I. None of the samples
displayed PAP I labeling (data not shown). To con®rm these
observations, total RNA extracted from normal and transformed
melanocytes and from four of 12 melanoma tumors were subjected
to RT-PCR with speci®c primers for PAP-I. No ampli®cation
products could be detected, contrary to what occurs in colon
carcinoma cells (Rechreche et al, 1999), demonstrating that normal
and transformed melanocytes did not express signi®cant amounts of
PAP-I.
As PAP-I is a stress protein, we looked for a possible induction of
its mRNA following exposure of normal and transformed
melanocytes to a genotoxic stress. Cells were subjected to either
0.2 mM hydrogen peroxide for 1 h, 100 mJ per cm2 UVB, or
100 mM cis-platin for 30 min, three agents known to induce DNA
damage and cell stress within minutes to hours by different
mechanisms. Again, no transcript could be detected by RT-PCR
after 18 h, con®rming that PAP-I is not synthesized by human
melanocytic cells even after stress (data not shown).
Adenovirus-mediated PAP-I transfer to human melano-
cytes and melanoma cells can modify their adhesion to
extracelluar matrix components Because melanocytic cells do
not produce PAP-I, they are an interesting model for studying
biologic properties of PAP-I, provided its ectopic expression can be
instrumentally achieved. We examined the effect of ectopic PAP-I
expression on cell adhesion and migration of normal and
transformed melanocytes. For this purpose, we used the
pDE1sp1B adenoviral shuttle vector in which CMV promoter
and either PAP-I cDNA (Ad-PAP-I) or CAT cDNA (control,
Ad-CAT) had been inserted (see Materials and Methods). The PAP-I
was produced in most cells at different levels depending on the cell
type or adenoviral multiplicity of infection, as determined by
immunocyto¯uorimetry and indirect immuno¯uorescence assay
(Fig 1).
Adhesion of melanocytic cells expressing PAP-I or control CAT
to extracellular matrix components was monitored in static
adhesion assays. Figure 2 shows that Ad-PAP-I transfer to normal
melanocytes as well as to SK-MEL-2 and KAL melanoma cell lines
resulted in lower adhesion rates (19%±24% less) on laminin-1 and
®bronectin, whereas no signi®cant changes were evidenced on
collagen I (or collagen IV, data not shown). To check whether
reduced adhesion rates on laminin-1 and ®bronectin were related
to modi®cations in expression of the integrins that mediate cell-
substratum adhesion, quanti®cation of cell surface integrin subunits
was performed by ¯ow cyto¯uorimetry using speci®c antibodies to
these subunits. PAP-I expression in normal human melanocytes
resulted in 32% lower levels of the laminin-1-recognizing a3
subunit, but no changes could be noticed for the a6 subunit, the
other laminin receptor (Fig 3). No statistically signi®cant modi®c-
ation of the expression of any other integrin subunits occurred.
This is in agreement with the similar adhesion rates on collagen
observed for PAP-I- and CAT-expressing normal melanocytes,
which are mediated by integrin subunit a2. Nevertheless,
differences in adhesion rates to ®bronectin cannot be explained
by altered a5 and aV subunit levels, the proper ®bronectin
receptors, as no changes were observed. Concerning the trans-
formed cell lines SK-MEL-2 and KAL, no signi®cant variations in
any integrin expression levels occurred, which therefore cannot
account for lower adhesion rates on laminin and ®bronectin
ligands.
To check whether differences in adhesion rates of PAP-I-
expressing melanocytes compared with CAT-expressing melano-
cytes could be related to a modi®cation of their integrin binding
Figure 1. Infection of melanocytic cells with adenoviral shuttle
vector Ad-PAP results in intracellular PAP-I expression. (A) Normal
human melanocytes (NHM), SK-MEL-2, and KAL melanoma cell lines
were infected with pDE1sp1B-CMV-PAP construct (Ad-PAP) or
pDE1sp1B-CMV-CAT (control) construct (Ad-CAT) at 0, 40, and 100
multiplicity of infection per cell. Twenty-four hours after the removal of
viruses, cells were allowed to react with a speci®c polyclonal antibody to
human PAP-I (H8) in an indirect immuno¯uorescence assay and analyzed
by cyto¯uorimetry. Histograms report the ¯uorescence intensities of Ad-
PAP-infected cells, after subtraction of the background ¯uorescence
intensity of the corresponding Ad-CAT-infected cells. Percentages of
¯uorescent cells that express PAP are given. (B) Indirect immuno¯uores-
cence assay detection with antibody H8 of PAP from Ad-PAP-infected
normal human melanocytes at 40 multiplicity of infection per cell (left)
compared with Ad-CAT-infected normal human melanocytes (right) (scale
bar: 8.5 mm).
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properties, integrin-function-blocking antibodies were then used in
adhesion assays. As shown in Fig 4, a3 and a6 subunits had to be
blocked by antibodies P1B5 and GoH3, respectively, to synergic-
ally inhibit adhesion of CAT- or PAP-I-expressing melanocytes on
laminin-1. Therefore, both integrin subunits are involved in
laminin-1 recognition, although other receptors should be involved
as antibodies did not totally abolish cell adhesion. Although
adhesion rates of melanocytes to laminin-1 are somewhat low,
however, the synergic inhibition is higher in CAT cells (38.5%)
than in PAP-I cells (27%). This phenomenon is better evidenced
with ®bronectin ligand because adhesion rates are twice as high as
those on laminin-1. To maximally inhibit cell attachment, both
integrin subunits a5 and aV had to be blocked by antibodies
SAM1 and V1, respectively, even if they are not the only receptors
Figure 2. Adhesion of human melanocytic cells to extracellular
matrix components can be modi®ed by infection with Ad-PAP.
Normal human melanocytes (NHM), SK-MEL-2, and KAL melanoma cell
lines were infected with pDE1sp1B-CMV-PAP construct (Ad-PAP, black
boxes) or pDE1sp1B-CMV-CAT control construct (Ad-CAT, gray boxes)
and assayed 24 h after the removal of viruses. Cells were allowed to adhere
for 1 h on immobilized laminin, ®bronectin, and collagen I as described in
Materials and Methods. Adhesion is expressed as the optical density (OD) of
adherent cells stained by crystal violet (mean 6 SEM, n = 3; Ad-PAP vs Ad-
CAT: *p < 0.1, NS = not signi®cant).
Figure 3. Cell surface expression of integrin a chains in human
melanocytic cells infected with Ad-PAP and Ad-CAT is almost
unchanged. Normal human melanocytes (NHM), SK-MEL-2, and KAL
melanoma cell lines were infected with pDE1sp1B-CMV-PAP construct
(Ad-PAP, black boxes) or pDE1sp1B-CMV-CAT control construct (Ad-
CAT, gray boxes). Twenty-four hours after the removal of viruses, they
were allowed to react with speci®c integrin a-chain antibodies and the
corresponding ¯uorophore-conjugated secondary antibody. Fluorescence
was determined by ¯ow cytometry.
Figure 4. Loss of integrin-dependent adhesion to some extracellular
matrix components of human melanocytes infected with Ad-PAP.
Normal human melanocytes (NHM) were infected with pDE1sp1B-CMV-
PAP construct (Ad-PAP, black boxes) or pDE1sp1B-CMV-CAT control
construct (Ad-CAT, gray boxes) and assayed 24 h after the removal of viruses
as described in Materials and Methods. Adhesion rates were evaluated as
indicated in Fig 1 (mean 6 SEM, n = 3; *p < 0.1, NS = not signi®cant). Ab:
integrin-function-blocking antibody.
Figure 5. Haptotactic migration of some melanocytic cells infected
with Ad-PAP is enhanced on laminin-1, ®bronectin, and collagen
I. Normal human melanocytes (NHM), SK-MEL-2, and KAL melanoma
cell lines were infected with pDE1sp1B-CMV-PAP construct (Ad-PAP,
black boxes) or pDE1sp1B-CMV-CAT control construct (Ad-CAT, gray
boxes) and assayed 24 h after the removal of viruses in the phagokinetic track
assay (mean 6 SEM, n = 8; *p < 0.1, NS = not signi®cant).
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involved (adhesion is not totally abolished by combination of the
two function-blocking antibodies). Consistently, prevention of
attachment by antibodies led to higher inhibition rates for CAT-
expressing rather than PAP-I-expressing melanocytes (54% vs
14.5% when both subunits are blocked).
Adenovirus-mediated PAP-I transfer to human melano-
cytes and melanoma cells can modify their migratory
behavior The random migration of melanocytic cells
expressing CAT and PAP-I on immobilized extracellular matrix
components (haptotactic migration) was quantitated after 4 h
(Fig 5). Motility of human melanocytes homing adenoviral
vectors was very low on laminin-1, ®bronectin, or collagen I
compared with melanoma cell lines. No differences in migration
rates could be detected between CAT- and PAP-I expressing
melanocytes. Whereas Ad-PAP-I transfer to the SK-MEL-2 line
did not change haptotactic migration on the three extracellular
matrix components signi®cantly, a striking difference was seen with
the KAL cell line. PAP-I expression resulted in, respectively, 10, 6,
and 14 times more migration on laminin-1, ®bronectin, and
collagen I. Therefore, PAP-I expression promotes migration of
some melanoma cells.
To complete investigations on cell motility, we assessed the in
vitro invasion behavior of PAP-adenovirus-transferred melanocytic
cells using ®bronectin as chemoattractant. To determine the
combination of invasion and directed movement (transmigration)
of melanocytic cells, the ®lters of Boyden chambers were coated
with Matrigel, which provides basement membrane components,
whereas in another set of experiments the ®lters were not coated to
study only directed movement. Compared with their Ad-CAT
transferred counterparts, melanocytes and KAL melanoma cells
homing Ad-PAP-I displayed an approximately 2.8-fold increase in
chemotactic directed movement (Fig 6), whereas transmigration of
SK-MEL-2 melanoma cells was unchanged. On Matrigel-coated
®lters, none of the melanocytic cells expressing PAP-I displayed
signi®cant differences in transmigration rates compared with their
CAT-transferred counterparts.
Effect of exogenous puri®ed rat PAP-I protein on directed
movement of noninfected melanocytic cells The availability
of puri®ed rat PAP-I protein being limited, the in¯uence of
exogenous PAP-I on melanocytic cells could not be thoroughly
tested. We focused on the in¯uence of PAP-I on the directed
movement of cells (transmigration), because it is modi®ed upon
PAP-I adenoviral transfer and the assay needs minimum volumes of
incubation medium.
Puri®ed PAP-I (1 or 10 ng per ml, 60 or 600 pM) was added to
the culture medium of normal human melanocytes, SK-MEL-2,
and KAL cell lines in the directed movement assay. SK-MEL-2 was
not responsive, whereas in KAL melanoma cells directed move-
ment was stimulated 1.6- and 2-fold by 1 and 10 ng per ml of
PAP-I, respectively (Fig 7A). Thus, in these two cell lines,
exogenous PAP-I mimics the effects obtained by PAP-I adenoviral
transfer. Directed migration of normal human melanocytes,
however, did not increase upon exogenous addition of PAP-I,
Figure 6. Directed movement of some melanocytic cells infected
with Ad-PAP is enhanced in transmigration assays. Normal human
melanocytes (NHM), SK-MEL-2, and KAL melanoma cell lines were
infected with pDE1sp1B-CMV-PAP construct (Ad-PAP, black boxes) or
pDE1sp1B-CMV-CAT control construct (Ad-CAT, gray boxes) and assayed
24 h after the removal of viruses on uncoated (transmigration) or Matrigel-
coated (invasion) Boyden chamber ®lters. Results are expressed as the
number of melanocytic cells observed per microscopic ®eld (mean 6 SEM;
n = 8; *p < 0.01, NS = not signi®cant).
Figure 7. Stimulation of directed movement of human melanocytic cells, human keratinocytes, and human ®broblasts in the presence of
puri®ed PAP-I. Normal human melanocytes (NHM), SK-MEL-2, and KAL melanoma cell lines (A) as well as human epidermal keratinocytes and dermal
®broblasts (B) were assayed for directed movement in the presence of 0, 1, and 10 ng per ml puri®ed rat PAP-I protein in uncoated Boyden chambers.
Results are expressed as the stimulation factor of movement obtained by comparison with cells that migrated in the absence of exogenous PAP-I (mean
6 SEM; n = 8). Statistical signi®cance versus 0 ng per ml PAP-I (control): (A) normal human melanocytes, NS = not signi®cant; SK-MEL-2, NS = not
signi®cant; KAL, *p < 0.03, **p < 0.03; (B) ®broblasts and keratinocytes, *p = 0.02, **p < 0.02.
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even when the PAP-I amount was brought to 100 ng per ml (data
not shown), contrary to normal human melanocyte cells upon
PAP-I adenovirus infection.
Next, we wondered whether exogenous addition of PAP can
modify transmigration of other cutaneous cells. Therefore, the same
experiments were performed on cultured human keratinocytes and
dermal ®broblasts. The two cell types showed a dose-dependent
response to exogenous PAP-I. Epidermal keratinocytes showed the
highest stimulations of directed movement: 2 and 5 times at 1 and
10 ng per ml of PAP-I, respectively, compared with 1.6 and 1.9
times for dermal ®broblasts (Fig 7B).
Melanocytic cells that can modify directed movement upon
exogenous PAP-I addition also display changes in spreading
capacities Finally, we determined whether the spreading
capacity of melanocytic cells on immobilized ®bronectin could
be altered by 10 ng per ml PAP-I in the culture medium. Actin
staining with rhodamine-phalloidin allowed us to monitor
cytoskeleton changes induced by PAP-I (Fig 8). Considering
normal human melanocytes, SK-MEL-2, and KAL cell lines,
only the latter, which also displayed modi®cation of directed
movement (see above), showed major visible changes in cell
spreading, 1 h after seeding. Spreading was enhanced by exogenous
PAP-I, as demonstrated by the observation of large spread cells,
pseudopod emissions, and fewer round-shaped cells, compared
with control.
DISCUSSION
Previous studies have shown that PAP-I, a stress protein identi®ed
in acute pancreatitis, can be expressed in extra-pancreatic locations
during neoplastic transformation such as hepatocarcinoma (Christa
et al, 1996), pituitary adenoma (Bartoli et al, 1998), and
gastrointestinal cancers (Christa et al, 1996; Montalto et al, 1998).
PAP-I was also detected in the bloodstream in concentrations
ranging from 1 nM in unaffected individuals to 200 nM in some
pathologies (Iovanna et al, 1994; van der Pijl et al, 1996). Our
results showed that PAP-I was not expressed to signi®cant levels in
cultured melanocytes from normal human skin, in transformed
melanocyte cell lines, nor in melanoma tumors. In addition,
contrary to AR4-2 J pancreatic cells (Ortiz et al, 1998), cell stress
generated by hydrogen peroxide, UVB light irradiation, or the
genotoxic drug cis-platin was also unable to induce protein
expression. Therefore, PAP-I is not a melanocytic protein. Because
PAP-I circulates in the blood stream, however, in¯uence of
exogenous PAP-I on melanocytes remains possible.
To induce PAP-I expression, we used, in the human
melanocytic model, the pDE1sp1B adenoviral shuttle vector in
which CMV promoter and PAP-I cDNA had been inserted. Such
adenovirus-mediated transfer of genes has proven more ef®cient in
various cell types than other methods such as plasmid transfer,
particularly when the cells have a short life span and a low
replication rate as displayed by normal melanocytes (Kuroki et al,
1999). Accordingly, we found that 54%±92% of melanocytes and
melanoma cells expressed the PAP (or GFP) following adenovirus
infection compared with only 15% when using plasmid transfection
(data not shown). Interestingly, we observed that PAP-I expression
resulted in reduced adhesion of melanocytic cells on laminin and
®bronectin, with a concomitant increase in haptotactic motility for
some melanoma cells (KAL cell line, and - data not shown - SK-
MEL-5 cell line). Cyto¯uorimetry showed that decreased adhesion
of melanocytes expressing PAP-I could not be attributed to a loss of
cell surface integrin receptors involved in substrate recognition. It is
more likely to be due to decreased dependence of adhesion on
integrin receptors, as shown by decreased sensitivity to blocking
integrin function with antibodies. Similar results were obtained
with HBL and KAL melanoma cell lines (data not shown). This
demonstrates that PAP-I can interfere with inside-out integrin
signaling in cells. In addition, directed movement of melanocytic
cells mediated by soluble chemoattractants was also found to be
activated by PAP-I expression in melanocytes and in the melanoma
cell lines KAL and - data not shown - SK-MEL-5. Yet,
transmigration through Matrigel, which requires secretion of
matrix-degrading enzymes, especially from the metalloproteinase
family, or diminished levels of their natural inhibitors, was not
modi®ed (Werb, 1997; Kahari and Saarialho-Kere, 1999). These
data suggest that PAP-I does not activate signal transduction
pathways related to matrix-degrading enzymes or their inhibitors
such as tissue inhibitor of metalloproteinases-2, but rather interferes
with migration-associated molecules. These molecules are involved
in cytoskeletal changes and formation of ®lopods, lamellipods,
and focal contact complexes, responsible for cell locomotion
Figure 8. Exogenous PAP-I enhances the spreading of KAL
melanoma cells on ®bronectin. Normal human melanocytes (NHM)
(A, B), SK-MEL-2 (C, D), and KAL (E, F) melanoma cell lines, previously
cultivated for 3 h in the presence (left) or absence (right) of 10 ng per ml
PAP-I, were allowed to attach and to spread for 1 h on immobilized
®bronectin (30 mg per ml). The ®gure shows the immuno¯uorescence
staining of the cells after actin-binding of rhodamine-phalloidin (scale bar
8.5 mm).
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(Lauffenburger and Horwitz, 1996; Ridley et al, 1999; Schlaepfer
et al, 1999; Sheetz et al, 1999) and implicated in tumor
dissemination (Price et al, 1997). Such PAP-I-induced modi®c-
ations of the (actin) cytoskeleton properties were observed in KAL
melanoma cells in spreading experiments on immobilized ®bro-
nectin. Compared with control, enhanced spreading was detectable
within 1 h after seeding in the presence of 10 ng per ml of
exogenous PAP-I.
Finally, because PAP-I is a secretory protein whose expression,
in normal conditions, is not detectable in melanocytic cells, we
wondered whether the consequences of PAP-I expression in these
cells could be due to a paracrine effect, after the protein is secreted
to the medium. Limited availability of puri®ed PAP-I prompted us
to check this hypothesis in transmigration (directed movement)
assays, which need small amounts of protein. Results showed that
when migration of melanoma cells is increased after infection with
the PAP-I adenovirus, it is also increased by exogenous PAP-I.
Responsive melanoma cells also displayed modi®cations of their
cytoskeleton, with enhancement of spreading properties. Taken
together, the results suggest that, in infected cells, PAP-I is secreted
and modulates migration and spreading through a paracrine effect.
Although less likely, intracellular action of PAP-I after synthesis or,
for exogenous PAP-I, after endocytosis (especially the breakdown
peptides) cannot be ruled out. Finally, noninfected normal human
melanocytes did not respond to exogenous PAP-I, even at high
doses. A possible explanation could be that directed movement of
normal human melanocytes requires other stimuli. It is known that
normal human melanocyte cells in culture show poor constitutive
migration and require more exogenous factors than melanoma cells.
This is also illustrated in vivo by the dif®culty in obtaining
appropriate recolonization of vitiliginous lesions (Morelli et al,
1993; Horikawa et al, 1995; Vancoillie et al, 1999). One can
speculate that some of the factors that must cooperate with PAP-I
to modulate normal human melanocyte migration in vitro are
synthesized in response to perturbations induced by adenoviral
infection and/or intracellular expression of PAP-I, but this remains
to be demonstrated.
Interestingly, exogenous PAP-I also stimulated directed migra-
tion of dermal ®broblasts and epidermal keratinocytes, indicating
that PAP-I response is not restricted to melanocytic cells. Hence,
besides being potentially involved in melanoma development, PAP
may affect skin homeostasis of keratinocytes and dermal ®broblasts,
in possible relationship with carcinoma development.
In conclusion, this work provides evidence that PAP-I can modify
the adhesive and migratory properties of melanocytic skin cells,
probably through membrane receptors, with cell-type speci®c
responses. Supportedbydataobtained with transformedmelanocytes,
PAP-I could therefore interfere with adhesion and migration, two
important mechanisms that participate in melanoma progression.
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